Research on chinese medical treatment of refractory idiopathic thrombocytopenic purpuraChinese Full Text
ZANG Xiang,ZHOU Yu-hong(Zhejiang Chinese Medical University Affiliated First Hospital,Hangzhou 310006,Zhejiang,China)
Abstract: Refractory idiopathic thrombocytopenic purpura resists to glucocorticoids and splenectomy,resulting in difficulty in clinical treatment.Though choices are various,clinical effect is not ideal.Application of Rituximab and TPO,Romiplostin,Eltrombopag,IL-11 impoves the result.Chinese medical treatment which based on"Huo","Xu" and "Yu" can reach better effect through reducing toxicity,increasing effect,stabilizing patient condition,decreasing relapse.
- DOI:
10.13193/j.archtcm.2012.08.95.zhangx.015
- Series:
- Subject:
- Classification Code:
R259
- Mobile Reading
Read on your phone instantly
Step 1Scan QR Codes
"Mobile CNKI-CNKI Express" App
Step 2Open“CNKI Express”
and click the scan icon in the upper left corner of the homepage.
Step 3Scan QR Codes
Read this article on your phone.
- HTML
- CAJ Download
- PDF Download
Download the mobile appuse the app to scan this coderead the article.
Tips: Please download CAJViewer to view CAJ format full text.
Download: 308 Page: 1789-1792 Pagecount: 4 Size: 95K
Citation Network
Related Literature
- Similar Article
- Reader Recommendation
- Associated Author